Login / Signup

Combination of weekly streptozocin and oral S-1 treatment for patients of unresectable or metastatic pancreatic neuroendocrine neoplasms.

Hiroaki OnoAtsushi KudoKeiichi AkahoshiToshiro OguraKosuke OgawaDaisuke BanShinji TanakaMinoru Tanabe
Published in: Journal of cancer research and clinical oncology (2019)
STS1 treatment is an effective and safe therapeutic option for patients with advanced Pan-NEN.
Keyphrases
  • end stage renal disease
  • small cell lung cancer
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • peritoneal dialysis
  • combination therapy
  • radiation therapy
  • locally advanced